ArticleCancer medicine2021

Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non-small cell lung cancer.

Li-Yue Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.